Sorrel Wolowacz | Head European Health Economics
R.T.I. Health Solutions

Sorrel Wolowacz has more than 2 decades of experience in health economics consulting and 3 decades of experience in the health care industry, including health outcomes, clinical research, and product development. Her research experience is in the areas of economic modelling, real-world evidence, health utility estimation, resource use data (collected alongside trials, by medical record abstraction, surveys, or within databases), and formal health technology assessment submissions. Dr. Wolowacz also has experience in various therapeutic areas, including oncology (specifically lung, breast, ovarian, skin, sarcoma, and haematological cancers, targeted therapies as well as tumour-agnostic therapies), cardiovascular, respiratory, liver disease, arthritis, chronic pain, ophthalmology, and dermatology. She has participated in health technology appraisals in several countries, including the United Kingdom (National Institute for Health and Care Excellence and Scottish Medicines Consortium), Ireland (National Centre for Pharmacoeconomics), Australia (Pharmaceutical Benefits Advisory Committee), and Canada (Canadian Agency for Drug and Technologies in Health, Canadian Drug Review).